Pharma POOL
Dr. Isma BENATTIA
New R&D Head at Wyeth’s Consumer Division
Wyeth Consumer Healthcare, Madison, N.J., a division of global phar maceutical and healthcare products firm Wyeth, has named Isma Benattia, M.D., executive VP, global research and development. She is responsible for driv ing and prioritizing the division’s R&D efforts to effectively bring new products to market and manage the regulatory environment for Wyeth’s overthecounter products. Dr. Benattia was most recently VP, global labeling, at Wyeth Pharmaceuticals. She holds masters’ degrees in pharmacology and psy chotropic drugs from Paris IX University, in methodology of clinical research from Paris XI Lariboisire University, and in medical and marketing management from Paris XIII Uni versity. She earned her medical degree and board certification in psychiatry from the Uni versity of Algiers. Dr. Ian MCINNES ScheringPlough Expands Executive’s Role Sche r i ng P l ough , Kenilworth, N.J., has promoted Ian McInnes, Ph.D., to the expanded role of senior VP and president, global supply chain, from senior VP, global supply chain. The change reflects the new scope of the company’s global supply chain strategy, which now includes operations from Organon BioSciences, acquired in March last year. Dr. McInnes holds a B.S. in manufacturing technology and manufacturing management and a Ph.D. in manufacturing engineering and systems, both from the University of Strathclyde in Glasgow, Scotland. William RINGO Pfizer Appoints Strategic Planning Executive Pfizer, New York, has named William Ringo senior VP of strategy and business development. Mr. Ringo has served in senior executive roles at a number of lifesciences companies, including Eli Lilly and Abgenix. He is currently an executive in residence at Warburg Pincus and Sofinnova Ventures, as well as a board member of biopharmaceutical firm InterMune. Biotech POOL Mary ANDERSON Xoma Appoints VP of Business Development Xoma, a Berkeley, Calif.based biotechnolo gy company specializing in therapeutic antibod ies, has named Mary Anderson VP of business development. In this role, Ms. Anderson over sees licensing activities related to Xoma’s therapeutic pipeline and antibody technologies, support of the compa ny’s antibody collaborations business, and advancement of biodefense programs. Ms. Anderson was most recently executive director, global licensing and business devel opment for oncology, at MerckSerono. She received a B.S. in biochemistry from Cali fornia Polytechnic State University, San Luis Obispo, and an MBA from St. Mary’s College of California. Biopharmaceutical POOL Dr. Douglas AXELROD New R&D Executive at Ambrx Ambrx, San Diego, has appointed Douglas Axelrod, M.D., Ph.D., as senior VP for clinical research and develop ment. Dr. Axelrod joins Ambrx, a biopharmaceu tical company focused on the discovery and devel opment of proteinbased drugs, from Procter & Gamble, where he most recently served as VP of R&D for discovery, early development, and product development. He received a med ical degree from Baylor College of Medicine, and a doctorate from the department of cell biology at the same institution. Steven BLOOM Dr. Barry JONES Ziopharm Strengthens Leadership Ziopharm Oncology, New York, a biopharma ceutical company that develops and commercial izes cancer drugs, has announced two additions to its team. Steven Bloom has joined Ziopharm as VP, business development, from Parexel Internation al, where he served as global VP of business development and market ing. He received a B.S. in pharmacy from North eastern University. Barry Jones, Ph.D., was named senior VP, preclinical operations. Dr. Jones was most recently senior VP and chief sci TALENT POOL EXECUTIVE APPOINTMENTS AND PROMOTIONS IN THE HEALTHCARE INDUSTRY PV0508 Issue FINAL2 4/23/08 10:39 AM Page 106 107 PharmaVOICE M a y 20 08 TALENT pool entific officer at Point Therapeutics. Dr. Jones received a B.Sc. from Liverpool University and a Ph.D. in immunology from the University of Bristol, both located in the United Kingdom. Both Mr. Bloom and Dr. Jones operate out of the company’s Boston location. Dr. N. Anthony COLES Leadership Change at Onyx Onyx Pharmaceuti cals, Emeryville, Calif., has selected Anthony Coles, M.D., to succeed retiring President, Chair man and CEO Hollings Renton. Onyx is a bio pharmaceutical company focused on developing novel cancer therapeutics. Dr. Coles was most recently president and CEO of NPS Pharmaceuticals. He received a B.S. from The Johns Hopkins University, an MPH from Harvard University, and an M.D. from Duke University. Dr. Leslie HUDSON New CEO at AVI BioPharma Leslie Hudson, Ph.D., has joined AVI Bio Pharma as CEO, succeeding interim CEO Michael Forrest, who remains on the compa ny’s board of directors. AVI BioPharma, Port land, Ore., develops drugs to treat lifethreat ening diseases using thirdgeneration antisense and exonskipping technologies. Dr. Hudson most recently served as interim president and CEO of Nabi Biopharmaceuti cals. He received a bachelor’s degree summa cum laude in zoology from Imperial College and a Ph.D. from Middlesex Hospital Medical School, both at the University of London. Dr. Francois NADER NPS Promotes COO to President and CEO NPS Pharmaceuticals, a developer of spe cialty therapeutics for gastrointestinal and endocrine disorders, has named Francois Nader, M.D., as president and CEO. Dr. Nader joined NPS, Bedminster, N.J., in 2006 as chief medical and commercial officer, and was promoted to executive VP and chief oper ating officer last year. Dr. Nader received an MBA in business (healthcare) from the University of Tennessee and an M.D. from the Facult Franaise de Mdecine at Universit SaintJoseph in Beirut. He also holds graduate degrees in medical mar keting from ESCPEAP, a European business school with branches in Paris, London, Berlin, Madrid, and Turin, Italy; and in finance from ESSEC Business School in Paris. Specialty POOL William HUMPHRIES New President at Stiefel Labs Stiefel Laboratories, Coral Gables, Fla., has promoted Chief Com mercial Officer William (Bill) Humphries to the position of president. The move marks the first time in the 160year history of the dermatology pharma ceutical company that someone outside of the Stiefel family has served as its president. Mr. Humphries continues to lead all sales, marketing, strategic communications, public relations, and commercial aspects of Stiefel’s global business from its global sales and mar keting headquarters in Duluth, Ga. He also assumes responsibility for Glades Pharmaceuti cals, a wholly owned Stiefel subsidiary special izing in the sales and marketing of generics. Mr. Humphries has a B.A. from Bucknell Univer sity and an MBA from Pepperdine University. Abid RAWN Depomed Appoints Marketing VP Abid Rawn has joined specialty pharmaceutical company Depomed, Menlo Park, Calif., as VP of sales and marketing. Mr. Rawn is involved with all aspects of the company’s commercial operations, from strategic product selection through commercialization. He holds B.S. degrees in pharmacy and zoology from the University of Wyoming. Genomics POOL Dr. Michelle LYLES Febit Hires Marketing Executive Febit Holding has appointed Michelle Lyles, Ph.D., to the newly created position of VP, marketing and sales, responsible for man aging marketing and sales initiatives for Febit’s genomics technology products and ser vices in the United States. Febit has operations in Heidelberg, Germany, and Medford, Mass., where Dr. Lyles is based. Dr. Lyles was most recently director of sales at SigmaAldrich’s research biotechnology business unit. She received B.S. degrees in biology and chemistry from the University of New Orleans and a Ph.D. in biochemistry at Baylor College of Medicine. Jonathan SHERIDAN HTG Hires VP of Operations HTG, Tuscon, Ariz., a provider of novel arraybased gene expression assay technology and services for the lifesciences industry, has appointed Jonathan Sheridan VP of commer cial operations to manage its second office in Madison, Wis. Mr. Sheridan is responsible for forming new business partnerships with pharmaceuti cal and lifesciences companies, establishing research agreements with academic institu tions, and managing the global commercial sales and marketing teams. Mr. Sheridan was previously director of sales and corporate development for Epicentre Biotechnologies. He received a B.S. in chem istry from Lambuth University. Emerging POOL Dr. Christopher BUSSINEAU Eric KARPINSKI NewVPs at BioVascular BioVascular, a privately held, San Diego based company focused on developing novel therapies for targeting plateletmediated dis eases, has expanded its executive team with two new appointments. Christopher Bussineau, Ph.D., has been named VP of pharmaceutical operations. Dr. Bussineau was previously VP and general manager of Cambrex Bio Science Baltimore. He has a B.A. in chemistry from the Universi ty of California, San Diego, and a Ph.D. in chemical engineering from Rice University. Eric Karpinski joins BioVascular as VP, business development and nonvascular opera tions. Mr. Karpinski most recently served as a PV0508 Issue FINAL2 4/23/08 10:39 AM Page 107 TALENT pool venture capitalist with Forward Ventures. He received a B.S. in biochemistry from Brown University and an MBA from the Wharton School of Business at the University of Penn sylvania. Dr. Richard GREGG Vitae Pharmaceuticals Appoints Chief Science Officer Richard Gregg, M.D., has joined Vitae Pharmaceuticals as chief science officer. Vitae, Fort Washington, Pa., is an emerging phar maceutical company focused on the discovery and development of smallmolecule medicines. Dr. Gregg was most recently VP, clinical discovery, at BristolMyers Squibb. He received B.S. and M.S. degrees in biochemistry from Iowa State University, and an M.D. from Stanford University. Dr.Timothy LOWINGER Mersana Names Head of Science Mersana Therapeutics has appointed Tim othy Lowinger, Ph.D., chief scientific officer responsible for advancing the company’s lead oncology products. Mersana, Cambridge, Mass., uses its proprietary nanotechnology platform to transform existing and experimen tal anticancer agents into new, patentable drugs. Most recently, he was VP of chemistry and pharmaceutical sciences at Angiotech Phar maceuticals. Dr. Lowinger received a B.Sc. in chem istry and a Ph.D. in organic chemistry from the University of British Columbia in Van couver. Agency POOL Janine ANNECHINO Bernadette COSGROVE Pacific Communications Expands Account Team Janine Annechino and Bernadette Cos grove have joined fullservice healthcare agen cy Pacific Communications, Costa Mesa, Calif., as account supervisors. Ms. Annechino was previously account supervisor at Cambridge BioMarketing. She is a graduate of Ohio State University. Ms. Cosgrove has 10 years of experience in pharmaceutical marketing and strategic com munications, most recently as marketing com munications manager at Amgen. She is a graduate of Franklin & Marshall College. Stacy AUER Kaelin DEZELAN Donald HANSON Tommy SCHENCK AbelsonTaylor Strengthens Account,Creative Staff Independent health care advertising agency AbelsonTaylor, Chicago, has made several promo tions and additions to its account and creative ser vices teams. Stacy Auer has joined AbelsonTaylor as account supervisor, responsible for manag ing an account in the women’s health area. Most recently, Ms. Auer was account super visor at DraftFCB in Chicago. She has a B.A. in marketing from the Art Institute of Illinois. Kaelin Dezelan has been promoted to senior account supervisor from account supervisor, with continued responsibility for products in the cardi ology, gastroenterology, and women’s health fields. Ms. Dezelan received a B.A. in arts communi cation from Denison University. Donald Hanson has joined AbelsonTaylor as senior account executive, with responsibility for managing an account for the treatment of GERD. Mr. Hanson was previously senior account executive at inVentiv. He received a BSBA in management and finance from Columbia Col lege. Tommy Schenck has been promoted to account supervisor from senior account execu tive. In this role, he is working on a recently won account in the antiinfective category. He holds a bachelor’s degree in business administration from Ohio University. Dr. Janet WOODCOCK FDA Names CDER Director The United States Food and Drug Administration has appointed Janet Woodcock, M.D., director of the agency’s Center for Drug Evaluation and Research (CDER), charged with assuring that safe and effective prescription and overthecounter drugs are available to Americans. Dr. Woodcock, previously the FDA’s deputy commissioner and chief medical officer, has served as acting director of CDER since October. A prominent FDA scientist and execu tive, Dr. Woodcock has played an integral role in advancing the health of the Ameri can public. Under her leadership, the FDA launched the Critical Path Initiative designed to bridge the gap between basic scientific research and the medical product development process. This initiative called for a collaborative crosssector effort to modernize the drug development process and has resulted in several prominent partnerships looking at a wide variety of scientific issues. Dr. Woodcock contin ues to be involved in this ini tiative, as well as the emerg ing postmarket surveillance collaborations with the pri vate sector. Dr. Woodcock received an M.D. from Northwestern Medical School. She has received numerous awards, including a Presidential Rank Meritorious Executive Award, the American Medical Associa tion’s Nathan Davis Award, the American Association for Cancer Research Public Service Award, the National Organization for Rare Disorders Public Health Leader ship Award, the Personalized Medicine Coalition’s Award for Leadership in Per sonalized Medicine, the National Alliance for Hispanic Health’s VIDA Award, and six Special Citations from FDA Commis sioners. Dr. Janet Woodcock 108 M a y 20 08 PharmaVOICE PV0508 Issue FINAL2 4/23/08 10:39 AM Page 108 TALENT pool Tracy BAKER John CATANIA Todd JACKSON Beth KUCHINKA Denise LEO Grant MILLER Jeffrey PROSPAL Karen SANFORD Navicor Group Announces Promotions Navicor Group, Columbus, Ohio, an inVentiv Health company, has promoted sev eral members of its account and creative teams. Navicor Group is a healthcare advertis ing agency specializing in oncology and immunology. Tracy Baker has been promoted to account director from account supervisor. John Catania has been promoted to group art supervisor from senior art director. Todd Jackson has been promoted to senior account executive from account executive. Beth Kuchinka has been promoted to senior account medical specialist from account medical specialist. Denise Leo has been pro moted to group copy supervisor from senior medical marketing writer. Grant Miller has been promoted to account executive from account coordinator. Jeffrey Prospal has been promoted to art director from associate art director. Karen San ford has been promoted to senior account exec utive from account executive. Paul BALAGOT Kevin DEEGAN Ross FETTERLOFF Kelly GOERES Pat MACKE Lisa MATSON Laura PFISTER Greg REISER Sean VASSILAROS NewVPs at Ignite Health Ignite Health, Irvine, Calif., has promoted several members of its accounts and creative services teams to the VP level. Ignite, an inVentiv Health company, is a marketing agency that specializes in patientcentered medical advertising. Paul Balagot has been promoted to VP, account services director, from the previous position of account services director. Kevin Deegan has been named VP, associate creative director. Mr. Deegan was previously director of creative strategy. Ross Fetterloff has been promoted to VP, account services director, from account services director. Kelly Goeres has been promoted to VP, metrics and analytics, from director of metrics. Pat Macke and Lisa Matson have been pro moted to VP, associate creative directors, from associate creative directors. Laura Pfister has been named VP, interac tive search and media director. Ms. Pfister was most recently director of interactive services. Greg Reiser has been promoted to VP, account serv ces director, from account services director. Sean Vassilaros has been promoted to VP, executive producer, from executive producer. Jigna BARANELLO Kristy CARABELLO Jason DECKER Sue ELAM Lori GIORGINO Tara ROGERS Jayme WATSON Jack WILSON SamWUNDERLE New Hires, Promotions at Torre Lazur McCann Torre Lazur McCann (TLM) has announced several promotions and additions to its account and creative teams. Jigna Baranello has joined TLM as account group supervisor, from the same position at Ferguson. Kristy Carabello has been promoted to VP, management supervisor. Jason Decker has been hired as senior copywrit er. Mr. Decker held the same position at Integrat ed Communications. Sue Elam has been promoted to VP, director of editorial services and word processing. Lori Giorgino has joined TLM as senior account executive. Ms. Giorgino previously worked for Ferguson and Qi. Tara Rogers has been appointed VP, account group supervisor. And Jayme Watson has joined TLM as account supervisor. Jack Wilson has been named VP, manage ment supervisor. Mr. Wilson previously worked at Pfizer, where he managed the Lipi tor business. Sam Wunderle has been hired as VP, account group supervisor. Laura BAUMANN Danielle BEDARD Nicole CHLOPECKI Sharon JOHNSON Alyson REISINGPOPA Paula TANCREDI PENMAN Staff Changes at Palio Advertising and com munications company Palio, Saratoga Springs, N.Y., an inVentiv Health company, has announced promotions among its account and creative staff. Laura Baumann has been promoted to account supervisor from her previous role as account executive. Danielle Bedard has been promoted to account director from account supervisor. Nicole Chlopecki has been promoted to account supervisor from account executive. Sharon Johnson has been appointed VP/ account director. Ms. Johnson was previously an account director at J. Walter Thompson New York. She earned a bache lor’s degree from the Uni versity of Connecticut. Alyson ReisingPopa has joined Palio as account executive. Most recently, she served as marketing director/ human resources at 109 PharmaVOICE M a y 20 08 PV0508 Issue FINAL2 4/23/08 10:39 AM Page 109 110 M a y 20 08 PharmaVOICE TALENT pool Saratoga Peak Performance/Orthopedic Asso ciates of Saratoga. Paula Tancredi Pen man has been appointed VP/account service. Ms. Tancredi Pen man received a bache lor’s degree from Rut gers University and an MBA from the Yale School of Management. Shannon BECKWITH David BOWERS Charles BROPHY David BUGAY Alexandra BUJNO Lauren COHEN Wayne FASSETT Janel HARRIS Kendell HICKS John JAKOVLIC Claire JESTER Brian KEYS Rob KIDDER Dennis LEAHY Grace MANDYBUR Susan ORZELBIGGS Lori PHOENIX Donna RARDAIN Stacy RICHARD Julia RIGA Dan SMITH Sarah SWEENY John TABOR Treva WEAVER Steve YUAN Promotions at GSWWorldwide Healthcare advertising agency GSW Worldwide, an inVentiv Health company, has announced a number of promotions at its Columbus, Ohio, headquarters, as well as its offices in New York and Pennsylvania. At its Columbus location, GSW has pro moted Shannon Beckwith to art director from associate art director. And David Bowers has been appointed executive creative director. Mr. Bowers was most recently chief operating officer. At its Newtown, Pa., office, GSW has pro moted Charles Brophy to senior account exec utive from account executive. David Bugay has been named VP, design director — business communications group, at the Columbus office. Previously, Mr. Bugay was design director, business development and marketing. In the New York office, Alexandra Bujno has been named senior account executive, account director. Previously, Ms. Bujno was account executive. At its Newtown, Pa., office, GSW has pro moted Lauren Cohen to senior account execu tive from account executive. Wayne Fassett has been promoted to VP/creative director at the Columbus office. Mr. Fassett was previously creative director. In Newtown, Janel Harris has been pro moted to account director from account exec utive. In Columbus, Kendell Hicks has been appointed director, international creative operations. Mr. Hicks most recently served as associate director of creative operations. John Jakovlic has been promoted to senior VP, director of process excellence, from VP, direc tor of process excellence. Claire Jester has been promoted to the position of account executive. Ms. Jester was previously account coordinator. Brian Keys has been promoted to group art supervisor in New York. Mr. Keys was previ ously art supervisor. Rob Kidder has been promoted to senior account executive from account executive in the Columbus office. Dennis Leahy, who previously held the post of associate creative director, has been promot ed to VP/creative director at the Columbus office. In the New York office, Grace Mandybur has been promoted to group art supervisor, having been previously conceptual art special ist. Susan OrzelBiggs has been promoted to VP, director of editorial services, from director of editorial services. In Newtown, Lori Phoenix has been pro moted to VP, account director, from account director. In Columbus, Donna Rardain has been named creative services group director. Previ ously, she was creative services supervisor. Stacy Richard has been promoted to art director from her previous role as graphic artist. Julia Riga has been promoted to senior account executive from account executive. Also in Columbus, Dan Smith has been promoted to executive VP, executive director of client services, from senior VP, managing director. In New York, Sarah Sweeny has been pro moted to account executive from assistant account executive. While in Newtown John Tabor has been promoted to VP, creative services, from direc tor, creative services. Treva Weaver has been named senior VP, director of strategy/financial operations in the Columbus office. Previously, Ms. Weaver was senior VP, director of financial analysis. Steve Yuan has been appointed VP, group planner. He most recently was VP, planner. David BENOWITZ Centron Adds to MedicalEducation Team Centron, New York, a fullservice medical com munications agency and part of the HealthStar Communications net work, has named David Benowitz senior VP, director of client services, of its medical education division. Mr. Benowitz was most recently VP, team leader, at The Impact Group. Noel CASTRO Dave GRILLO Kelly HUGHES Brand Pharm Unveils Management Changes New Yorkbased healthcare advertising agency Brand Pharm, a Publicis Healthcare Communications Group company, has created a new management structure to support its continuing growth. Noel Castro and Dave Grillo have assumed joint leadership of the creative department as senior VP, executive creative director, art, and senior VP, executive creative director, copy, respectively. Kelly Hughes has been promoted to exec utive VP, director of client services, from senior VP, group account director. She is responsible for building integrated strategies. Jessica CINO Jodi SMITH New Hires at Noesis Noesis, CommonHealth’s professional PV0508 Issue FINAL2 4/23/08 10:39 AM Page 110 111 PharmaVOICE M a y 20 08 TALENT pool advertising and promo tion unit based in Parsip pany, N.J., has announced new addi tions to its team. Jessica Cino has joined Noesis as an art director. Most recently, Ms. Cino was an assistant art director at Beacon Healthcare Communica tions. Jodi Smith has been hired as a senior imaging specialist. He previously worked as a senior digital designer at Torre Lazur McCann. Diane DEPAOLIS Fernando FERNANDEZ Derek LOVE Y Brand Promotes Staff Y Brand, New York, an inVentiv Health company and strategic consulting group pro viding branding solutions, has announced the promotion of three staff members. Diane DePaolis has been promoted to VP, creative director, from VP, design director. Fernando Fernandez and Derek Love have been promoted to senior art directors from their previous positions of art director. Robert JOHNSTONE Sam LOWE Temilyn (Temi) MEHTA Eileen O’BRIEN Stephen PEARSON Christine ROBBINS Staff Additions, Promotions at Compass Healthcare Compass Healthcare Communications, an independent, fullservice online and relationship marketing agency based in Princeton, N.J., has hired and promoted several staff members. Robert Johnstone has been appointed account executive. Mr. Johnstone was most recently with Netplus Marketing. Sam Lowe has been named creative direc tor. Mr. Lowe has more than 20 years of cre ative experience in the healthcare and busi nesstobusiness sectors, most recently as creative director of Lanmark Group. He attended the University of Kentucky. Temi Mehta has been appointed account supervisor. Previously, she worked at Kurani Interactive. Eileen O’Brien has joined Compass as director of online promotions. Ms. O’Brien most recently served as director of interactive media at Engel Publishing Partners. She received an A.B. in history from Brown University and an M.S. in organizational dynamics from the University of Pennsylva nia. Stephen Pearson has been promoted to director of operations from his previous role as account supervisor. Christine Robbins was promoted to senior account executive from account executive. Ms. Robbins attended Juniata College. Tom JONES WeissComm Names Managing Director WeissComm Part ners, San Francisco, an independent communi cations agency focused on the healthcare indus try, has appointed Tom Jones managing director. Mr. Jones was previously executive director of communications at Novartis Pharmaceuticals. He graduated magna cum laude from Rowan University and received a master’s in commu nications from New York University. Steve MARTORANA Photosound Adds Staff Photosound, a Health Star Communications company based in Plains boro, N.J., has announced the appointment of Steve Martorana as account manager. Mr. Martorana has extensive experience in management and business development, most recently with H.B. Stubbs Companies. Megan OLLINGER Cadent Medical Communications Names Account Director Cadent Medical Communications, an inVentiv Health company and medical com munications specialist, has promoted Megan Ollinger to account director from her previous role as account supervisor. Ms. Ollinger attended Pennsylvania State University. Paul O’NEILL ICC Appoints General Manager Integrated Commu nications (ICC), a full service healthcare mar keting communications agency and part of Lowe Healthcare Worldwide, has promoted Paul O’Neill to general man ager of its flagship loca tion in Parsippany, N.J., from executive VP, director of client services. He holds a B.S. in biology from Cornell University. Libby WILSON HC&B Adds Senior Executive Independent health care agency HC&B Healthcare Communica tions, Austin, Tex., has hired Libby Wilson as a senior account executive. Ms. Wilson received a B.S. in journalism from the University of Kansas. CRO POOL Steven AGNOFF Jeffrey BAGSHAW Susan JALBERT Daniel MARKS Inclinix Shuffles Executive Team Inclinix, an enroll ment CRO based in Wilmington, N.C., has made several additions and changes to its execu tive team. Steven Agnoff has joined Inclinix as VP of marketing and product management. Previous ly, Mr. Agnoff held exec utive leadership and business development roles with several indus try organizations. Jeffrey Bagshaw has been promoted to senior PV0508 Issue FINAL2 4/23/08 10:39 AM Page 111 112 M a y 20 08 PharmaVOICE TALENT pool VP of sales from his pre vious role as VP of med ical marketing and communications. Mr. Bagshaw received a B.S. in mar keting from the Univer sity of Tennessee at Knoxville. Susan Jalbert has joined Inclinix as direc tor of North American sales. Daniel Marks has been named VP of cor porate development. Before joining Inclinix, Mr. Marks held execu tive management roles within the technology and medical services sectors. John CLINE Cato Research Appoints President Cato Research, a fullservice contract research organization based in Durham, N.C., has named industry veteran John Cline as its president. He replaces cofounder Allen Cato, M.D., Ph.D., who remains CEO of the com pany. Mr. Cline has more than 25 years of experience in the pharmaceutical industry, most recently as president and CEO of etrials Worldwide. Jacque FISHER Parexel Appoints VP to Communications Business Contract research services and consulting firm Parexel International, Boston, has hired Jacque Fisher as a VP and general manager in Parexel’s medical communications services business. Ms. Fisher leads a global team of experts to assist clients in translating complex scientific information into integrated commu nications to accelerate product adoption and professional recommendations. Ms. Fisher was most recently president of GardinerCaldwell U.S. She received a bache lor’s degree from University College London. Dr.Wilson Blaine KNIGHT Southern Research Names Drug Discovery VP Southern Research Institute, Birmingham, Ala., has appointed Wilson Blaine Knight, Ph.D., VP of its drug discovery division. Pre viously, Dr. Knight served in a number of executive roles at GlaxoSmithKline, including VP of nonclinical glob alization projects/pre clinical development, VP of strategic alliances, VP of screening sciences, and VP of systems research in the discovery research directorate. Dr. Knight received a bachelor’s degree in chemistry from Universi ty of Virginia and a Ph.D. in biochemistry from the University of Maryland. Dr. Rebecca LI NERI Promotes Research Executive Specialty CRO New England Research Insti tutes (NERI), Water town, Mass., has promot ed Rebecca Li, Ph.D., to VP of clinical research. Dr. Li most recently served as principal research scientist and clinical director. She received a Ph.D. in biomolecular and chemical engineering from The Johns Hopkins University. Vito MANGIARDI Bilcare GCS Announces Leadership Changes As part of its continued global expansion, Bilcare Global Clinical Supplies has appointed industry veteran Vito Mangiardi as CEO. Bil care is a singlesource provider of quality clin icaltrial materials to clients across the Amer icas, Europe, and Asia through its locations in Phoenixville, Pa.; Pune, India; and South Wales, United Kingdom. Mr. Mangiardi most recently was president of North American operations at AAI Pharma. He received a B.S. in biology and chemistry from the Eastern University of Illinois, and MBAs in general management and marketing from Golden Gate University. Media POOL Kathryn DARIENZO Penelope SCOTT MediZine Strengthens Sales Staff MediZine, a New Yorkbased consumer health educational marketing and publishing firm, has added two executives to its sales team to support the expansion of the compa ny’s Remedy Direct Digital business. Kathryn Darienzo has been appointed sales director. Ms. Darienzo was most recently busi ness development direc tor at RealAge, a sub sidiary of Hearst Magazines. She attended Columbus University. Penelope Scott has joined MediZine as VP, sales and marketing, from Time, where she was senior sales executive at Time and Time.com and senior VP, Americas advertising sales, at Time International. Ms. Scott is a graduate of the University of London. MedicalEducation POOL Ed EGUIZABAL Zackary LENTZ Katie MCCARTHY The Center for Biomedical Continuing Education (CBCE), Irving, Texas, an inVentiv Health company and provider of continuing medical education, has announced the promo tion of several associates. Ed Eguizabal has been promoted to pro duction manager from educational program coordinator. Zackary Lentz has been promoted to senior VP from VP. Katie McCarthy has been promoted to director, meeting and events, from her previous role as meeting and events manager. Janine SCOTTI Promotion at PeerPoint PeerPoint Medical Education Institute, Evanston, Ill., an inde pendent subsidiary of MedPoint Communica tions, has promoted Janine Scotti to director of education services. Ms. Scotti is responsible for overseeing the company’s accreditation department and project management. Ms. Scotti joined PeerPoint in January 2005 PV0508 Issue FINAL2 4/23/08 10:39 AM Page 112 113 PharmaVOICE M a y 20 08 TALENT pool and has been responsible for execution of the education grantfunded projects. She received a B.S. from Siena College and an MBA in mar keting from the University of Phoenix. Service POOL Dr. Mark AMMANN Dr. LaVonne LANG UBC Expands Regulatory Affairs Group United BioSource (UBC), a global pharma ceutical services organiza tion based in Bethesda, Md., has added two exec utives to its regulatory affairs group. The group, based in Ann Arbor, Mich., provides a full range of services to UBC’s pharmaceutical and biotechnology clients. Mark Ammann, Pharm.D, has been named VP, regulatory affairs, with responsibili ty for heading the regu latory affairs group. A 17year pharmaceutical industry veteran, Dr. Ammann was most recently global head of regulatory affairs at Pfizer. He received a Pharm.D. from the University of Michigan. LaVonne Lang, Dr.P.H., has joined UBC as senior director, regulatory affairs. Dr. Lang has 18 years of experience in pharmaceutical devel opment, with 12 years in regulatory strategy at ParkeDavis and Pfizer. A licensed registered nurse, Dr. Lang holds an MPH in environmen tal and industrial health, and a doctorate in public health policy, both from the University of Michigan. Susan BEACH New Sales VP at Publicis Selling Solutions Publicis Selling Solu tions, a Lawrenceville, N.J.based provider of sales teams and support services to the biopharma ceutical industry, has named Susan Beach VP of sales. Publicis Selling Solutions is part of the Publicis Selling Solutions Group, a Publicis Healthcare Communications Group (PHCG) company. Ms. Beach was previously executive VP of Pharmagistics, another PHCG company. David COX SalesForce4Hire Enters Spine, Orthopedic Market SalesForce4Hire, a provider of custom sales solutions to the medical device and lifesciences industries, has entered the spine and orthopedic sec tor with the appointment of David Cox as VP in charge of orthopedic development. In its new specialty area, SalesForce4Hire, Cary, N.C., offers marketing and sales support for emerging spinal devices and treatment solutions and innovative osteobiological products. Mr. Cox was previously owner and operator of ZimmerCox Associates. He received a B.A. from North Carolina State University. Jade CUSICK Ziment Custom Promotes VP Ziment Custom, the New Yorkbased strategic primary marketing research division of Ziment Group, has pro moted Jade Cusick to executive VP, strategic relationships, from senior VP, strategic relationships. Dr. Camm EPSTEIN MediMedia Adds Head of Market Research MediMedia has appointed Camm Epstein, Ph.D., VP, mar ket research, responsible for leading a dedicated department to support the company’s market research initiatives. MediMedia is a healthcare communications, publishing, and medicaleducation services provider with headquarters in Chatham, N.J. Dr. Epstein is based in the company’s Yard ley, Pa., office. He received a B.A. in biology and psychol ogy from Rutgers College, an MPH from Columbia University, and a Ph.D. in public administration from New York University. Andrea HILLER New Marketing Manager at Kalorama Kalorama Information has appointed Andrea Hiller marketing manager at its New York office. Kalorama provides market data, trends, and analysis in medical industries, including biotechnology, diagnostics, health care, medical devices, and pharmaceuticals. Richard (Tex) KUND MTI Hires Development VP Pharmaceutical mar keting services firm MTI Information Technolo gies, Langhorne, Pa., has appointed Tex Kund VP, business development. Mr. Kund was most recently director of busi ness development at PDI. He received a bachelor’s degree in business administration from Temple University. Philip LUBY PharmaCentra Expands Leadership PharmaCentra, an Atlantabased market ing and services firm that provides customiz able healthcare management programs, has appointed Philip Luby VP of new business development. Mr. Luby was previously direc tor of strategic accounts for the WebMD net work. Technology POOL Paula MCHALE ClinPhone Strengthens EDC Team Paula McHale has joined ClinPhone as director of product management, data man agement solutions, with responsibility for the company’s electronic data capture (EDC) product. Ms. McHale was previously world wide director, EDC solutions, at Parexel Inter national. ClinPhone, Princeton, N.J., is a spe cialist clinical technology organization working with global biotech and pharmaceu tical organizations. Send your personnel announcements to feedback@pharmavoice.com. PV0508 Issue FINAL2 4/23/08 10:39 AM Page 113
